Kardigan targets three patient groups with $660.7 million in liquid assets

Verifying
  • Kardigan is focusing on three patient groups across cardiac and hypertension conditions.
  • $660.7 million in liquid assets provides Kardigan with a runway of about ...
  • The groups include genetic dilated cardiomyopathy, moderate valve stenosis and post-hospitalization severe hypertension.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.